Skip to content

Clinical trials

Phase 3 Venous Thromboembolism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Venous Thromboembolism Phase: Phase 3 Country / region: United States Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20063
20073
20089
20093
20102
20111
20121
20132
20143
20153
20162
20173
20222
20241
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting6
Terminated5
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer7
Sanofi7
Boehringer Ingelheim4
Regeneron Pharmaceuticals4
Daiichi Sankyo3
Anthos Therapeutics, Inc.2
Johns Hopkins All Children's Hospital2
Academic and Community Cancer Research United1
Cedars-Sinai Medical Center1
Crux Biomedical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Venous Thromboembolism46
Pulmonary Embolism17
Venous Thrombosis17
Neoplasms8
Thrombosis6
Thromboembolism4
Postthrombotic Syndrome2
Atrial Fibrillation1
Brain Neoplasms1
Colitis, Ulcerative1

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.